EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

B cells in the progression from metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma: immune regulation, microenvironmental crosstalk, and therapeutic implications

Hengqi Bai, Gexu Fan, Botong Deng, Yang Liu, Pengyu Zhang, Xinfang Cao, Yanjun Li

International Immunopharmacology · 2026

DOI: 10.1016/j.intimp.2026.117306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026. Verfasst von Hengqi Bai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, B-Lymphocytes, Fatty Liver. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B cells exert stage-dependent and highly heterogeneous immunoregulatory functions throughout the progression from metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma. Their functional states are shaped by disease stage, the metabolic milieu, and tissue-specific immune niches, thereby influencing hepatic inflammation, fibrotic remodeling, the tumor immune microenvironment, and responses to immunotherapy. During metabolic dysfunction-associated steatotic liver disease, particularly metabolic dysfunction-associated steatohepatitis, aberrantly activated B cells may promote hepatic inflammation through autoantibody production, secretion of pro-inflammatory cytokines, and antigen presentation. Alterations in the abundance or immunosuppressive activity of regulatory B cells may further disrupt local immune homeostasis. During liver fibrosis, B cells interact with macrophages, T cells, and hepatic stellate cells, contributing to extracellular matrix deposition and tissue remodeling. At the hepatocellular carcinoma stage, B cells display marked functional duality. Certain B-cell subsets support antitumor immunity by promoting the formation of tertiary lymphoid structures, whereas immunosuppressive B-cell subsets may impair CD8+ T-cell function, facilitate immune evasion, and promote tumor progression. This review summarizes the phenotypic characteristics, functional heterogeneity, and intercellular interactions of B cells throughout disease progression. It also discusses therapeutic strategies for modulating dysregulated B-cell states and integrating B-cell-targeted approaches with immunotherapy. Stratification by disease stage, etiology, and B-cell functional subset may support the development of precision therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularB-LymphocytesFatty LiverHumansAnimalsDisease ProgressionTumor MicroenvironmentImmunotherapy

Stichwörter der Autor:innen

B cellsHepatocellular carcinomaLiver fibrosisMetabolic dysfunction-associated steatotic liver diseaseTertiary lymphoid structures

Autor:innen und Institutionen

  • Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
  • Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
  • Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China; Department of Hepatobiliary Surgery, Shanxi Bethune Hospital, Shanxi Acad…

Zitieren

APA

Bai, H., Fan, G., Deng, B., Liu, Y., Zhang, P., Cao, X., & Li, Y. (2026). B cells in the progression from metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma: immune regulation, microenvironmental crosstalk, and therapeutic implications. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117306

Vancouver

Bai H, Fan G, Deng B, Liu Y, Zhang P, Cao X, et al. B cells in the progression from metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma: immune regulation, microenvironmental crosstalk, and therapeutic implications. International Immunopharmacology. 2026. doi:10.1016/j.intimp.2026.117306

BibTeX
@article{Bai2026,
  author = {Bai, Hengqi and Fan, Gexu and Deng, Botong and Liu, Yang and Zhang, Pengyu and Cao, Xinfang and Li, Yanjun},
  title = {B cells in the progression from metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma: immune regulation, microenvironmental crosstalk, and therapeutic implications},
  journal = {International Immunopharmacology},
  year = {2026},
  doi = {10.1016/j.intimp.2026.117306}
}
Kostenlos starten →